GB0619262D0 - Compositions and methods for treating skin conditions - Google Patents

Compositions and methods for treating skin conditions

Info

Publication number
GB0619262D0
GB0619262D0 GBGB0619262.9A GB0619262A GB0619262D0 GB 0619262 D0 GB0619262 D0 GB 0619262D0 GB 0619262 A GB0619262 A GB 0619262A GB 0619262 D0 GB0619262 D0 GB 0619262D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
skin conditions
treating skin
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0619262.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB0619262.9A priority Critical patent/GB0619262D0/en
Publication of GB0619262D0 publication Critical patent/GB0619262D0/en
Priority to GB0718918A priority patent/GB2453157A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0619262.9A 2006-09-29 2006-09-29 Compositions and methods for treating skin conditions Ceased GB0619262D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0619262.9A GB0619262D0 (en) 2006-09-29 2006-09-29 Compositions and methods for treating skin conditions
GB0718918A GB2453157A (en) 2006-09-29 2007-09-28 Compositions and their use for treating skin conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0619262.9A GB0619262D0 (en) 2006-09-29 2006-09-29 Compositions and methods for treating skin conditions

Publications (1)

Publication Number Publication Date
GB0619262D0 true GB0619262D0 (en) 2006-11-08

Family

ID=37434943

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0619262.9A Ceased GB0619262D0 (en) 2006-09-29 2006-09-29 Compositions and methods for treating skin conditions
GB0718918A Withdrawn GB2453157A (en) 2006-09-29 2007-09-28 Compositions and their use for treating skin conditions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0718918A Withdrawn GB2453157A (en) 2006-09-29 2007-09-28 Compositions and their use for treating skin conditions

Country Status (1)

Country Link
GB (2) GB0619262D0 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2468127A (en) * 2009-02-25 2010-09-01 Ajit Lalvani Cosmetic or pharmaceutical preparation for the skin
GB0920846D0 (en) 2009-11-27 2010-01-13 Croda Int Plc Defenin inducing agent
DE102010030443A1 (en) * 2010-06-23 2011-01-05 Lr Health & Beauty Systems Gmbh Cosmetic composition, useful e.g. for the prophylaxis and treatment of dry sensitive skin or eczematous and psoriatic skin, comprises cobalamin and an extract of plant of the family Berberidaceae, preferably from the genus Mahonia
JP5889220B2 (en) * 2012-03-30 2016-03-22 富士フイルム株式会社 Aqueous dispersion composition
DE202013008190U1 (en) 2013-09-17 2013-12-05 Pg Naturpharma Gmbh Preparation and its use in atopic dermatitis
EP3852872B1 (en) * 2018-09-18 2023-08-23 Fadim Ltd Composition for the treatment of the oral cavity
DE102022116686A1 (en) * 2022-07-05 2024-01-11 Skincura Gmbh Skin dressing and method for producing a skin dressing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002320251A1 (en) * 2001-07-05 2003-01-21 Vital Basics, Inc. Compositions for improving mental performance
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use

Also Published As

Publication number Publication date
GB2453157A (en) 2009-04-01
GB0718918D0 (en) 2007-11-07

Similar Documents

Publication Publication Date Title
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
IL257681A (en) Methods and compositions for treating cancer
IL202015A0 (en) Methods and compositions for treating skin conditions
HK1125868A1 (en) Compositions and methods for treating bone
EP1959929A4 (en) Compositions and methods for treating dermatological conditions
IL202573A0 (en) Methods and compositions for treating allergic diseases
EP2124985A4 (en) Methods and compositions for treating neuropathies
IL193014A0 (en) Methods and compositions for treating schizophrenia
EP2088952A4 (en) Methods and devices for treating tissue
EP2170309A4 (en) Methods and compositions for treating disorders
IL186963A0 (en) Methods and compositions for treating pain
EP1890712A4 (en) Compositions and methods for treating pain
HK1245679A1 (en) Methods and compositions for treating dermatological diseases and conditions
IL210097A0 (en) Compositions and methods for treating unfluenza
ZA200900140B (en) Methods and compositions for treating biofilms
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP2049151A4 (en) Methods and compositions for the treatment of cancer
EP2056849A4 (en) Methods and compositions for treating ige-mediated diseases
GB0718918D0 (en) Compositions and methods for treating skin conditions
HK1129596A1 (en) Methods and compositions for treating disease
EP1993564A4 (en) Method and composition for treating allergic diseases
EP2094279A4 (en) Methods and compositions for treating influenza
GB0519334D0 (en) Method and composition for treating skin
ZA201001779B (en) Compositions and methods for treating collagen-mediated diseases
EP2068629A4 (en) Compositions and methods for treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)